Characteristics of the in vitro vasoactivity of β-amyloid peptides

Experimental Neurology

Volumn 150, Issue 1, 1998, Pages 159-168

  Crawford, Fiona ^a   Suo, Zhiming ^a   Fang, Chunhong ^a   Mullan, Mike ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Alzheimer's disease; Cerebral amyloid angioplasty; Endothelin 1; Vasoactivity; Amyloid

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; FREE RADICAL; SUPEROXIDE DISMUTASE;

AGE; ALZHEIMER DISEASE; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; CYTOTOXICITY; MALE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR AMYLOIDOSIS; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

EID: 0032032969     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6743     Document Type: Article

References (46)

1. Banati R., Gehrmann J., Wiessner C., Hossmann K., Kreutzberg G. Glial expression of the beta-amyloid precursor protein (APP) in global ischemia. J. Cereb. Blood Flow Metab. 15:1995;647-654.
2. Behl C., Davis J. Amyloid beta-peptide induces necrosis rather than apoptosis. Brain Res. 645:1994;253-264.
3. Boulanger C., Schini V., Moncada S., Vanhoutte P. Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide. Br. J. Pharmacol. 101:1990;152-156.
4. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat. Med. 3:1997;67-72.
5. Davenport A., Kuc R., Maguire J., Harland S. ETA receptors predominate in the human vasculature and mediate constriction. J. Cardiovasc. Pharmacol. 26:1995;S265-S267.
6. De Oliveira A., Viswanathan M., Capsoni S., Heemskerk F., Correa F., Saavedra J. Characterization of endothelin A receptors in cerebral and peripheral arteries of the rat. Peptides. 16:1995;139-144.
7. Duff K., Eckman C., Zehr C., Yu X., Prada C. M., Perez-tur J. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin-1. Nature. 383:1996;710-713.
8. Ehrenreich H., Schilling L. New developments in the understanding of cerebral vasoregulation and vasospasm: The endothelin-NO network. Cleveland Clin. J. Med. 62:1995;105-116.
9. Gibson G., Martins R., Blass J., Gandy S. Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients. Life Sci. 59:1996;477-489.
10. Greenberg S., Vonsattel J., Stakes J., Gruber M., Finkelstein S. The clinical spectrum of cerebral amyloid angiopathy: Presentations without lobar hemorrhage. Neurology. 43:1993;2073-2079.
11. Hall E., Oostveen J., Dunn E., Carter D. Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Exp. Neurol. 135:1995;17-27.
12. Haynes W. Endothelins as regulators of vascular tone in man. Clin. Sci. 88:1995;509-517.
13. 2+2++. J. Biol. Chem. 263:1988;9292-9297.
14. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
15. Hsu K., Lin-Shiau S. Antagonism by paraquat of the relaxing effects of acetylcholine and A23187 in rat thoracic aorta. Eur. J. Pharmacol. 292:1995;315-320.
16. Hunley T., Iwasaki S., Homma T., Kon V. Nitric oxide and endothelin in pathophysiological settings. Pediatr. Nephrol. 9:1995;235-244.
17. Iversen L., Mortishire-Smith R., Pollack S., Shearman M. The toxicityin vitro. Biochem. J. 311:1995;1-16.
18. Jendroska K., Poewe W., Daniel S., Pluess J., Iwerssen-Schmidt H., Paulsen J. Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain. Acta Neuropathol. 90:1995;461-466.
19. Kalaria R. The blood brain barrier and cerebral microcirculation in Alzheimer's disease. Cerebrovasc. Brain Metab. Rev. 4:1992;226-260.
20. Kalaria R., Bhatti S., Lust W., Perry G. The amyloid precursor protein in ischemic brain injury and chronic hypoperfusion. Ann. N. Y. Acad. Sci. 695:1993;190-193.
21. Kalaria R., Premkumar D., Pax A., Cohen D., Lieberburg I. Production and increased detection of amyloid β-protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease. Mol. Brain Res. 35:1996;58-68.
22. Kawahara J., Izumi H., Okada Y., Izawa T. Effects of the potassium channel openers KRN4884 and levcromakalim on the contraction of rat aorta induced by A23187, compared with nifedipine. Naunyn Schmiedebergs Arch. Pharmacol. 354:1996;460-465.
23. Kawai M., Kalaria R., Cras P., Siedlak S., Velasco M., Shelton E. Degeneration of amyloid precursor protein containing smooth muscle cells in cerebral amyloid angiopathy. Brain Res. 623:1993;142-146.
24. Kelly J. F., Furukawa K., Barger S. W., Rengen M. R., Mark R. J., Blanc E. M. Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. USA. 93:1996;6753-6758.
25. Kogure K., Kato H. Altered gene expression in cerebral ischemia. Stroke. 24:1993;2121-2127.
26. May P. C., Gitter B. D., Waters D. C., Simmons L. K., Becker G. W., Small J. S. Beta-amyloid peptide in vitro toxicity: Lot-to-lot variability. Neurobiol. Aging. 13:1992;605-607.
27. Minami M., Kimura M., Iwamotot N., Arai H. Endothelin-1-like immunoreactivity in cerebral cortex of Alzheimer-type dementia. Prog. Neuro-psychopharmacol. Biol. Psych. 19:1995;509-513.
28. Olichney J., Hansen L., Hofstetter R., Grundman M., Katzman R., Thal L. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch. Neurol. 52:1995;702-708.
29. Palacios G., Mengod G., Tortosa A., Ferrer I., Palacios J. Increased beta-amyloid precursor protein expression in astrocytes in the gerbil hippocampus following ischemia: Association with proliferation of astrocytes. Eur. J. Neurosci. 7:1995;501-510.
30. Pollard H., Arispe N., Rojas E. Ion channel hypothesis for Alzheimer amyloid peptide neurotoxicity. Cell. Mol. Neurobiol. 15:1995;513-526.
31. Prior R., D'Urso D., Frank R., Prikulis I., Pavlakovic G. Loss of vessel wall viability in cerebral amyloid angiopathy. Neuroreport. 7:1996;562-564.
32. Saito S., Hirata Y., Imai T., Marumo F. Autocrine regulation of the endothelin-1 gene in rat endothelial cells. J. Cardiovasc. Pharmacol. 26:1995;S84-S87.
33. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increasedin vivo. Nat. Med. 2:1996;864-870.
34. Singer H. Endothelium-dependent relaxation of rabbit aorta. II. Inhibition of relaxation stimulated by methacholine and A23187 with antagonists of arachidonic acid metabolism. J. Pharmacol. Exp. Ther. 226:1983;796-801.
35. Slooter A. J. C., Tang M.-X., van Duijn C. M., Stern Y., Ott A., Bell K. Apolipoprotein E ε4 and the risk of dementia with stroke. J. Am. Med. Assoc. 227:1997;818-821.
36. Smith D., Hitchcock M., Philpott P. Cerebral amyloid angiopathy presenting as transient ischemic attacks. J. Neurosurg. 63:1985;963-964.
37. Snowdon D. A., Greiner L. H., Mortimer J. A., Riley K. P., Greiner P. A., Markesbery W. R. Brain infarction and the clinical expression of Alzheimer disease. J. Am. Med. Assoc. 227:1997;813-817.
38. 1-42. Brain Res. 762:1997;144-152.
39. Thomas T., Thomas G., McLendon C., Sutton T., Mullan M. β-amyloid mediated vasoactivity and vascular endothelial damage. Nature. 380:1996;168-171.
40. Thomas T., McLendon C., Truitt Sutton E., Thomas G. Cerebrovascular endothelial dysfunction mediated by β-amyloid. Neuroreport. 8:1997;1387-1391.
41. Wisniewski H., Wegiel J. The neuropathology of Alzheimer's disease. Neuroimag. Clin. N. Am.; Neurodegener. Dis. 5:1995;45-57.
42. Woods A., Cribbs D. Heparan sulfate and chondroitin sulfate glycosaminoglycan attenuate beta-amyloid (25-35) induced neurodegeneration in cultured hippocampal neurons. Brain Res. 697:1995;53-62.
43. Xie H., Triggle C. Endothelium-independent relaxations to acetylcholine and A23187 in the human umbilical artery. J. Vasc. Res. 31:1994;92-105.
44. Yamashita T. Potassium channel openers relax A23187-induced nifedipine-resistant contraction of rat aorta. J. Cardiovasc. Pharmacol. 24:1994;914-920.
45. Yoskizawa T., Iwamoto H., Mizusawa H., Suzuki N., Matsumoto H., Kanazawa I. Cerebrospinal fluid endothelin-1 in Alzheimer's disease and senile dementia of Alzheimer type. Neuropeptides. 22:1992;85-88.
46. Zhang W., Badonic T., Hoog A., Jiang M., Ma K., Nie X. Astrocytes in Alzheimer's disease express immunoreactivity to the vasoconstrictor endothelin-1. J. Neurolog. Sci. 122:1994;90-96.